Fred Hutch spinout lands $10M for precision test to guide cancer treatment, develop drugs Seattle startup SEngine Precision Medicine has raised $10 million to propel drug discovery and development and advance its test that… Read More
Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient’s tumors Seattle startup SEngine Precision Medicine has raised $5.1 million in fresh funding as it looks to commercialize a platform that… Read More
